Potential anticancer effects of statins: Fact or fiction?

Varsha Kaushal, Manish Kohli, Paulette Mehta, Jawahar L. Mehta

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Deregulation of any of the steps in cell growth, proliferation and apoptosis may result in its malignant transformation. Statins, along with their lipid-Iowering potential, modify several processes in the cell cycle. These agents inhibit cell proliferation and arrest cell cycle progression by interrupting growth-promoting signals. Statins selectively induce proapoptotic protential in tumor cells and synergistically enhance proapoptotic potential of several cytotoxic agents. Statins alter angiogenic potential of cells by modulating apoptosis inhibitory effects of VEGF and decrease secretion of metalloproteases. Statins also alter adhesion and migration of tumor cells, thereby inhibiting tumor invasion and metastasis. Statins suppress rate of activation of multiple coagulation factors and thus prevent coagulation-mediated angiogenesis. Statins have been shown to have anti-tumor activity in experimental models. Various anti-neoplastic properties of statins are probably a result of inhibition of posttranslational modifications of growth regulatory proteins. Molecular mechanisms of antiproliferative, proapoptotic and antiangiogenic effects of statins are reviewed in this chapter.

Original languageEnglish (US)
Pages (from-to)49-58
Number of pages10
JournalEndothelium: Journal of Endothelial Cell Research
Volume10
Issue number1
DOIs
StatePublished - 2003
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Neoplasms
Growth
Cell Proliferation
Apoptosis
Blood Coagulation Factors
Cytotoxins
Metalloproteases
Post Translational Protein Processing
Cell Cycle Checkpoints
Vascular Endothelial Growth Factor A
Cell Movement
Cell Cycle
Theoretical Models
Neoplasm Metastasis
Lipids

Keywords

  • Angiogenesis
  • Apoptosis
  • Cancer
  • Statins

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Cite this

Potential anticancer effects of statins : Fact or fiction? / Kaushal, Varsha; Kohli, Manish; Mehta, Paulette; Mehta, Jawahar L.

In: Endothelium: Journal of Endothelial Cell Research, Vol. 10, No. 1, 2003, p. 49-58.

Research output: Contribution to journalArticle

Kaushal, Varsha ; Kohli, Manish ; Mehta, Paulette ; Mehta, Jawahar L. / Potential anticancer effects of statins : Fact or fiction?. In: Endothelium: Journal of Endothelial Cell Research. 2003 ; Vol. 10, No. 1. pp. 49-58.
@article{4a9ca071a65348f691d3d04321478c01,
title = "Potential anticancer effects of statins: Fact or fiction?",
abstract = "Deregulation of any of the steps in cell growth, proliferation and apoptosis may result in its malignant transformation. Statins, along with their lipid-Iowering potential, modify several processes in the cell cycle. These agents inhibit cell proliferation and arrest cell cycle progression by interrupting growth-promoting signals. Statins selectively induce proapoptotic protential in tumor cells and synergistically enhance proapoptotic potential of several cytotoxic agents. Statins alter angiogenic potential of cells by modulating apoptosis inhibitory effects of VEGF and decrease secretion of metalloproteases. Statins also alter adhesion and migration of tumor cells, thereby inhibiting tumor invasion and metastasis. Statins suppress rate of activation of multiple coagulation factors and thus prevent coagulation-mediated angiogenesis. Statins have been shown to have anti-tumor activity in experimental models. Various anti-neoplastic properties of statins are probably a result of inhibition of posttranslational modifications of growth regulatory proteins. Molecular mechanisms of antiproliferative, proapoptotic and antiangiogenic effects of statins are reviewed in this chapter.",
keywords = "Angiogenesis, Apoptosis, Cancer, Statins",
author = "Varsha Kaushal and Manish Kohli and Paulette Mehta and Mehta, {Jawahar L.}",
year = "2003",
doi = "10.1080/10623320303358",
language = "English (US)",
volume = "10",
pages = "49--58",
journal = "Endothelium: Journal of Endothelial Cell Research",
issn = "1062-3329",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Potential anticancer effects of statins

T2 - Fact or fiction?

AU - Kaushal, Varsha

AU - Kohli, Manish

AU - Mehta, Paulette

AU - Mehta, Jawahar L.

PY - 2003

Y1 - 2003

N2 - Deregulation of any of the steps in cell growth, proliferation and apoptosis may result in its malignant transformation. Statins, along with their lipid-Iowering potential, modify several processes in the cell cycle. These agents inhibit cell proliferation and arrest cell cycle progression by interrupting growth-promoting signals. Statins selectively induce proapoptotic protential in tumor cells and synergistically enhance proapoptotic potential of several cytotoxic agents. Statins alter angiogenic potential of cells by modulating apoptosis inhibitory effects of VEGF and decrease secretion of metalloproteases. Statins also alter adhesion and migration of tumor cells, thereby inhibiting tumor invasion and metastasis. Statins suppress rate of activation of multiple coagulation factors and thus prevent coagulation-mediated angiogenesis. Statins have been shown to have anti-tumor activity in experimental models. Various anti-neoplastic properties of statins are probably a result of inhibition of posttranslational modifications of growth regulatory proteins. Molecular mechanisms of antiproliferative, proapoptotic and antiangiogenic effects of statins are reviewed in this chapter.

AB - Deregulation of any of the steps in cell growth, proliferation and apoptosis may result in its malignant transformation. Statins, along with their lipid-Iowering potential, modify several processes in the cell cycle. These agents inhibit cell proliferation and arrest cell cycle progression by interrupting growth-promoting signals. Statins selectively induce proapoptotic protential in tumor cells and synergistically enhance proapoptotic potential of several cytotoxic agents. Statins alter angiogenic potential of cells by modulating apoptosis inhibitory effects of VEGF and decrease secretion of metalloproteases. Statins also alter adhesion and migration of tumor cells, thereby inhibiting tumor invasion and metastasis. Statins suppress rate of activation of multiple coagulation factors and thus prevent coagulation-mediated angiogenesis. Statins have been shown to have anti-tumor activity in experimental models. Various anti-neoplastic properties of statins are probably a result of inhibition of posttranslational modifications of growth regulatory proteins. Molecular mechanisms of antiproliferative, proapoptotic and antiangiogenic effects of statins are reviewed in this chapter.

KW - Angiogenesis

KW - Apoptosis

KW - Cancer

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=0037230916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037230916&partnerID=8YFLogxK

U2 - 10.1080/10623320303358

DO - 10.1080/10623320303358

M3 - Article

C2 - 12699077

AN - SCOPUS:0037230916

VL - 10

SP - 49

EP - 58

JO - Endothelium: Journal of Endothelial Cell Research

JF - Endothelium: Journal of Endothelial Cell Research

SN - 1062-3329

IS - 1

ER -